Genmab A/S
NASDAQ:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
Nandan Denim Ltd
NSE:NDL
|
IN |
|
Hamlin Bank And Trust Co
OTC:HMLN
|
US |
|
CESC Ltd
NSE:CESC
|
IN |
|
ProCredit Holding AG & Co KGaA
XETRA:PCZ
|
DE |
Wall Street
Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for
GMAB
is 95.18 USD
with a low forecast of 20.53 USD and a high forecast of 226.69 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMAB's stock price target?
Price Target
95.18
USD
According to Wall Street analysts, the average 1-year price target for
GMAB
is 95.18 USD
with a low forecast of 20.53 USD and a high forecast of 226.69 USD.
What is Genmab A/S's Revenue forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
Genmab A/S's revenue is
33%.
The projected
CAGR
for the next 3 years is
17%.
What is Genmab A/S's Operating Income forecast?
Projected CAGR
18%
The
compound annual growth rate
of Genmab A/S's operating income for the next 3 years is
18%.
What is Genmab A/S's Net Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Genmab A/S's net income for the next 3 years is
23%.
